DEMECAN Revenue and Competitors
Estimated Revenue & Valuation
- DEMECAN's estimated annual revenue is currently $13.1M per year.
- DEMECAN's estimated revenue per employee is $201,000
Employee Data
- DEMECAN has 65 Employees.
- DEMECAN grew their employee count by 0% last year.
DEMECAN's People
Name | Title | Email/Phone |
---|
DEMECAN Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $17.7M | 88 | 7% | N/A | N/A |
#2 | $89.4M | 445 | 9% | N/A | N/A |
#3 | $32.4M | 161 | 25% | N/A | N/A |
#4 | $44.4M | 221 | 7% | N/A | N/A |
#5 | $120.2M | 427 | 17% | $446.2M | N/A |
#6 | $54.3M | 270 | 10% | N/A | N/A |
#7 | $49.6M | 247 | 52% | N/A | N/A |
#8 | $21.9M | 109 | -1% | N/A | N/A |
#9 | $16.5M | 82 | 4% | N/A | N/A |
#10 | $26.7M | 133 | 25% | N/A | N/A |
What Is DEMECAN?
DEMECAN is a medicinal cannabis company focusing on the cultivation, importation and wholesale of medicinal cannabis. The firm has been officially selected to cultivate medicinal cannabis by the German government. The Company was founded in order to provide patients in Germany with the highest grade of medical cannabis in pharmaceutical quality. It is headquartered in Berlin, with import and wholesale branches and a separate cultivation facility in Dresden and the surrounding region respectively.
keywords:N/AN/A
Total Funding
65
Number of Employees
$13.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
DEMECAN News
Little Green Pharma's Danish operation will provide more than 1.3 tonnes of white-label flower to German distributor Demecan in a deal the...
Demecan must pay 50 per cent of the development costs of each strain successfully developed, subject to caps under the agreement. We are very...
Under the Agreement, LGP will supply Demecan with three high-THC strains (22% THC) for distribution in Germany. Demecan is required to purchase...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $12.3M | 65 | 33% | N/A |
#2 | $15.8M | 65 | N/A | N/A |
#3 | N/A | 65 | -20% | N/A |
#4 | N/A | 65 | 30% | N/A |
#5 | $19.2M | 66 | 3% | N/A |